Ser373
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser373  -  BKR2 (human)

Site Information
sMGTLRTsIsVERQI   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 447664

In vivo Characterization
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling ( 1 ) , mutation of modification site ( 1 ) , peptide sequencing ( 1 ) , phosphoamino acid analysis ( 1 ) , phosphopeptide mapping ( 1 )
Relevant cell line - cell type - tissue:
HEK293T (epithelial) ( 1 ) , HF-15 (fibroblast) ( 1 )

Upstream Regulation
Putative in vivo kinases:
GRK4 (human) ( 1 ) , PKCA (human) ( 1 )
Treatments:
bradykinin ( 1 ) , FR190997 ( 1 ) , phorbol_ester ( 1 )

Downstream Regulation
Effects of modification on BKR2:
receptor desensitization, altered ( 1 )

References 

1

Blaukat A, et al. (2001) Determination of bradykinin B2 receptor in vivo phosphorylation sites and their role in receptor function. J Biol Chem 276, 40431-40
11517230   Curated Info